While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...
But when the researchers analyzed the data, they found that fluoxetine appeared not to provide meaningful benefits for ...
FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...
Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...
Similarly, in a warning about compounded finasteride, the United States Food and Drug Administration stated in April 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback